| Literature DB >> 34564177 |
Abstract
Thraustochytrids are unicellular, heterotrophic marine eukaryotes. Some species are known to store surplus carbon as intracellular lipids, and these also contain the long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA). Most vertebrates are unable to synthesize sufficient amounts of DHA, and this fatty acid is essential for, e.g., marine fish, domesticated animals, and humans. Thraustochytrids may also produce other commercially valuable fatty acids and isoprenoids. Due to the great potential of thraustochytrids as producers of DHA and other lipid-related molecules, a need for more knowledge on this group of organisms is needed. This necessitates the ability to do genetic manipulation of the different strains. Thus far, this has been obtained for a few strains, while it has failed for other strains. Here, we systematically review the genetic transformation methods used for different thraustochytrid strains, with the aim of aiding studies on strains not yet successfully transformed. The designs of transformation cassettes are also described and compared. Moreover, the potential problems when trying to establish transformation protocols in new thraustochytrid species/strains are discussed, along with suggestions utilized in other organisms to overcome similar challenges. The approaches discussed in this review could be a starting point when designing protocols for other non-model organisms.Entities:
Keywords: Aurantiochytrium; Schizochytrium; electroporation; thraustochytrids; transformation
Mesh:
Substances:
Year: 2021 PMID: 34564177 PMCID: PMC8467673 DOI: 10.3390/md19090515
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1(a) The number of successfully engineered thraustochytrid strains by one or more methods (electroporation [20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52], biolistic transformation [5,27,53,54,55], and others [56,57,58,59]) (Tables S1 and S2). The doughnut pie charts indicate the proportion of different genera. Four strains have been transformed by more than one method: a A. limacinum mh018 and T. aureum ATCC 34304; b Schizochytrium sp. S31; c Schizochytrium sp. TIO1101; (b) The number of successfully transformed thraustochytrid strains and the methods applied in recent years. Any strain–method combinations are counted only once, even if they are used in several publications.
Figure 2The parameters prevalence and the procedure scheme of transformation by electroporation in thraustochytrid strains. Numbers in parentheses, the number of strains that have used the parameter in at least one publication (Table S1); NF, NucleofectorTM solution L; OM, OPTI-MEMTM I; Ionic buffers include BSS, artificial sea water and phosphate buffer; Non-ionic, buffers include 50 mM Sucrose, 1 M Sorbitol, water, PEG 8000; Enzyme, 20 g/L pectinase and 20 g/L snailase in 7 M KCl.
Figure 3The prevalence of constitutive promoters (a) and terminators (b) used in thraustochytrids genetic engineering. Strain numbers: the number of strains that have used the promoter/terminator in at least one publication (Tables S3 and S4).
Antibiotics used for selecting transformants of thraustochytrids.
| Strain | Zeocin | Hygromycin | G418 | Blasticidin | Other | Reference |
|---|---|---|---|---|---|---|
| 2000 | 500 | [ | ||||
| 500 * | 1000; 2000 * | 500 | 1200 | 500 (neomycin) | [ | |
| 5 | 100 (chloramphenicol) | [ | ||||
| 5 | 100 (chloramphenicol) | [ | ||||
| 30; 50; 100 | 200 | 500 | [ | |||
| 30 (cycloheximide) | [ | |||||
| 50 | [ | |||||
| 500 | 500 | [ | ||||
| 100 | [ | |||||
| 30; 50; 100 | 500 * | 50 *; 50 | 100 *(anhydrotetracycline) | [ | ||
| 50 | [ | |||||
| 15 | [ | |||||
| 2000 | 500 | 800 | [ | |||
| 40; 50 | 100 | 50 (bleomycin); 250 (cefotaxime); 50 (paromomycin) | [ | |||
| 1.5; 20 | [ | |||||
| 800 | [ | |||||
| 100 | [ | |||||
| 300 | [ | |||||
| 2000 | 500 | [ | ||||
| 20 | [ | |||||
| Thraustochytrid strain 12B | 500 | [ | ||||
| 2000 | 1000; 2000 | 200–400 | [ | |||
| 250 | 400 | [ |
Each number represents the minimal concentration (µg/mL) used on agar for transformant selection in the reference; * MIC identified in the reference that was not used in transformant selection. The references of each used concentration are shown in Table S5.